InvestorsHub Logo
icon url

erthang

10/04/05 2:56 PM

#1374 RE: good-pal #1369

goodpal reminds me an awful lot of DC-Steve. Could it be!
icon url

bocxman

10/04/05 2:57 PM

#1375 RE: good-pal #1369

good-pal, please explain this:
"the SEC investegating our bocx for "ACCURACY CLAIMS." so (in my eyes)Its a FACT that BOCX exaggerated there DATA a Little bit."

1) the SEC never announced a formal investigation

2) in this country, you are innocent until proven guilty. an investigation (if one existed) does not make BOCX's guilt a "FACT"

3) the accuracy of claims part of the SEC investigation has no merit, because BOCX already published the entire data set referred to in the P.R and presented it to ISOBM.

stick to the facts...don't just get emotional because you're losing money lol.


icon url

HALF FULL GLASS

10/04/05 3:12 PM

#1378 RE: good-pal #1369

Good-pal,

Similar is acceptable. This is what the FDA wants to see. If one knows how a marker will react each time it is used, one can predict what is going on inside the tumor. This is fantastic news because the same person is not going to administer the test all over the world. As long as each test is similar + / - a specific accuracy tolerance then the product can be used as a universal marker. I would venture to say that the actual approved PSA tests are not identical each time. As long as they are similar this is good.